Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus

Digestive and Liver Disease

Volumn 39, Issue SUPPL. 1, 2007, Pages

  De Re, V ^a,b,e   Caggiari, L ^a,e   De Vita, S ^b,c,e   Mazzaro, C ^b,d,e   Lenzi, M ^a,e   Galli, M ^b,e,f   Monti, G ^b,e,g   Ferri, C ^b,e,h   Zignego, A L ^b,e,i   Gabrielli, A ^b,e,j   Sansonno, D ^b,e,k   Dammacco, F ^b,e,k   Libra, M ^e,l   Sacchi, N ^e,m,n   Talamini, R ^a,e   Spina, M ^a,e   Cannizzaro, R ^a,e   Guidoboni, M ^a,e   Dolcetti, R ^a,e  

^a Aviano National Cancer Institute   (Italy)

^b ltalian Group Association for the Study of Cryoglobulinemia (ACRI)

^c UNIVERSITY OF UDINE   (Italy)

^d Pordenone Hospital

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g Saronno Hospital   (Italy)

^h UNIVERSITY OF PISA   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^k UNIVERSITY OF BARI   (Italy)

^l UNIVERSITY OF CATANIA   (Italy)

^m GALLIERA HOSPITAL   (Italy)

ⁿ Registro Italiano Donatori di Midollo Osseo ^*

more..

Author keywords

B cell lymphoma (NHL); Hepatitis C virus (HCV); Human leukocyte antigen (HLA) molecules; Type II mixed cryoglobulinemia (MC)

Indexed keywords

AMINO ACID; EPITOPE; GLUTAMINE; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DQ3 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR5 ANTIGEN; LEUCINE; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; ANTIGEN STRUCTURE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DONOR; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEPATITIS C; HOMOZYGOSITY; HUMAN; HYDROPHOBICITY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PROGNOSIS; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; CLUSTER ANALYSIS; CRYOGLOBULINEMIA; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR5 ANTIGEN; HUMANS;

EID: 35148863475     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(07)80014-4     Document Type: Article

References (33)

1. Ferri C., Greco F., Longobardo G., Palla P., Moretti A., Marzo A., et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 34 (1991) 1606-1610
2. Mele A., Pulsoni A., Bianco E., Musto P., Szklo A., Sanpaolo M., et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 102 (2003) 996-1002
3. Talamini R., Montella M., Crovatto M., Dal Maso L., Crispo A., Negri A., et al. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 110 (2004) 380-385
4. Thursz M., Yallop R., Goldin R., Trepo C., Thomas H., and The HENCORE group. Hepatitis C European Network for Cooperative Research. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 354 (1999) 2119-2124
5. Alric L., Fort M., Izopet J., Vinel J., Charlet J., Selves J., et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 113 (1997) 1675-1681
6. Minton E., Smillie D., Neal K., Irving W., Underwood J., James V., and Members of the Trent Hepatitis C Virus Study Group. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis 178 (1998) 39-43
7. Mangia A., Gentile R., Cascavilla I., Margaglione M., Villani M., Stella F., et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol 30 (1999) 984-990
8. Hue S., Cacoub P., Renou C., Halfon P., Thibault V., Charlotte F., et al. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis 186 (2002) 106-109
9. Tillmann H., Chen D., Trautwein C., Kliem V., Grundey A., Berning-Haag, et al. Low frequency of HLA-DRBI*11 in hepatitis C virus associated end stage liver disease. Gut 48 (2001) 714-718
10. Doytchinova I., and Flower D. In silico identification of supertypes for class II MHCs. J Immunol 174 (2005) 7085-7095
11. Brouet J., Clauvel J., Danon F., and Klein M. Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57 (1974) 775-788
12. Dinauer D., Luhm R., and Uzgiris A. Sequence-based typing of HLA class II DQB1. Tissue Antigens 55 (2000) 364-368
13. Kotsch K., Wehling J., and Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes. Tissue Antigens 53 (1999) 486-497
14. Breslow N., and Day N. Statistical methods in cancer research. Vol 1 - The Analysis of Case-Control Studies, IARC Sci Publ 32 1 (1980), IARC, Lyon 5-338
15. Caggiari L., Simula M., Marzotto A., Caragnano A., Luchetti M., Gabrielli A., et al. Identification of a novel human DRB1*13 allele by sequence-based DRB typing. Tissue Antigens 66 (2005) 246-247
16. Ossi E., Bordin M., Businaro M., Marson P., Bonadonna P., Chiaramonte M., et al. HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. Clin Exp Rheumatol. 13 Suppl 13 (1995) S91-S93
17. Congia M., Clemente M., Dessi C., Cucca F., Mazzoleni A., Frau F., et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 24 (1996) 1338-1341
18. Lenzi M., Frisoni M., Mantovani V., Ricci P., Muratori L., Francesconi R., et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 15 (1998) 2062-2066
19. Lenzi M., Frisoni M., Mantovani V., Ricci P., Muratori L., Francesconi R., et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 91 (1998) 2062-2066
20. Cacoub P., Renou C., Kerr G., Hue S., Rosenthal E., Cohen P., et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44 (2001) 2118-2124
21. Nagasaka A., Takahashi T., Sasaki T., Takimoto K., Miyashita K., and Nakamura M. Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study. J Med Virol 65 (2001) 52-57
22. Hwang S., Chu C., Huang D., Lan K., Chang F., and Lee S. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 59 (2002) 31-37
23. Sebastiani G., Bellisai F., Caudai C., Rottoli P., Valensin P., Pippi L., et al. Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients. J Biol Regul Homeost Agents 19 (2005) 17-22
24. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
25. Alric L., Fort M., Izopet J., Vinel J., Charlet J., Selves J., et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 113 (1997) 1675-1681
26. Godkin A., Jeanguet N., Thursz M., Openshaw P., and Thomas H. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol 31 (2001) 1438-1446
27. Diepolder H., Gerlach J., and Zachoval R. Immunodominant CD4+ T cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71 (1997) 6011-6019
28. Lamonaca V., Missale G., and Urbani S. Concerved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: implications for vaccine development. Hepatology 30 (1999) 1088-1098
29. Todd J., Bell J., and McDevitt H. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329 (1987) 599-604
30. Sollid L., Markussen G., Ek J., Gjerde H., Vartdal F., and Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169 (1989) 345-350
31. Zanelli E., Breedveld F., and de Vries R. HLA class II association with rheumatoid arthritis: facts and interpretations. Hum Immunol 61 (2000) 1254-1261
32. Rosenberg W. Mechanisms of immune escape in viral hepatitis. Gut 44 (1999) 759-764
33. Logunova N., Viret C., Pobezinsky L., Miller S., Kazansky D., Sundberg J., et al. Restricted MHC-peptide repertoire predisposes to autoimmunity. J Exp Med 202 (2005) 73-84